Document Detail

Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy.
MedLine Citation:
PMID:  20977823     Owner:  NLM     Status:  In-Process    
Almost half of the children with symptomatic dilated cardiomyopathy receive a transplant or die within 2 years; however, cardiac stem cell transplantation has become a promising therapeutic option. The present case demonstrates for the first time, to our knowledge, the intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill 4-month-old child with severe dilated cardiomyopathy. Left ventricular ejection fraction increased from 20% before stem cell transplantation to 41% at 4 months of follow-up.
Aris Lacis; Andrejs Erglis
Related Documents :
2574363 - In-utero transplantation of fetal liver haemopoietic stem cells in monkeys.
10523153 - Transplantation of thymus tissue in complete digeorge syndrome.
2985233 - Is mallory body formation a preneoplastic change? a study of 181 cases of liver bearing...
Publication Detail:
Type:  Journal Article     Date:  2010-10-27
Journal Detail:
Title:  Cardiology in the young     Volume:  21     ISSN:  1467-1107     ISO Abbreviation:  Cardiol Young     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9200019     Medline TA:  Cardiol Young     Country:  England    
Other Details:
Languages:  eng     Pagination:  110-2     Citation Subset:  IM    
Latvian Centre of Pediatric Cardiology, Children's Hospital, Riga, Latvia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Systemic venous collateral channel causing desaturation after bidirectional cavopulmonary anastomosi...
Next Document:  Ablation of atrial tachyarrhythmias late after surgical repair of tetralogy of Fallot.